Orthofix Medical (OFIX) Equity Average (2011 - 2026)

Orthofix Medical (OFIX) has 16 years of Equity Average data on file, last reported at $442.6 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 7.93% year-over-year to $442.6 million; the trailing twelve-month figure through Mar 2026 stood at $442.6 million (down 7.93% YoY), and the FY2025 full-year result was $476.6 million, down 13.49% from the prior year.
• Equity Average for Q1 2026 stood at $442.6 million, down from $446.3 million in the prior quarter.
• Across five years, Equity Average topped out at $652.1 million in Q2 2023 and bottomed at $335.2 million in Q4 2022.
• A 5-year average of $482.8 million and a median of $480.7 million in 2025 frame the typical range for Equity Average.
• Across the five-year window, Equity Average surged 92.49% in 2023 and dropped 17.89% in 2025, its largest moves.
• Tracing OFIX's Equity Average over 5 years: stood at $335.2 million in 2022, then jumped by 81.12% to $607.1 million in 2023, then fell by 15.25% to $514.5 million in 2024, then dropped by 13.27% to $446.3 million in 2025, then dropped by 0.82% to $442.6 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $442.6 million, $446.3 million, and $450.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison